Back to search results

LINKD Study for Diabetes Management

This study, called LINKD (Leveraging Interventions for Needs and Knowledge in Diabetes), is looking at different ways to help people with diabetes better manage their condition, especially if they face social or financial challenges. You might engage with FindHelp (a website/app connecting you to local resources), receive Peer Support from someone with diabetes experience, work with Social Work services, or get Financial Navigation support. The study is for adults aged 18 or older with a diabetes diagnosis (Type 1 or Type 2) who are taking medication and have a recent HbA1c (a measure of blood sugar control) of 7.5% or higher (or 8.0% for those over 70). The main goal is to see how these interventions affect your HbA1c and blood pressure over 12 months. The study plans to enroll 694 participants, but its current status is unclear.

Study design
This is an interventional study where participants will be randomly assigned to one or more support programs. It plans to enroll 694 participants.
What's involved
You will complete multiple surveys over a year. Your blood pressure and HbA1c (blood glucose) will be measured at baseline, 3 months, 6 months, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
You will be followed for 12 months after starting the study interventions.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07676188

Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD)

Recruiting
NAAges 18+InterventionalHealth services
University of Michigan
~694 participants
Updated 2026-08-05 on ClinicalTrials.gov
What's tested:FindHelpPeer SupportSocial WorkFinancial Navigation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
HbA1c
Measured over Labs will be drawn at 4 assessment points: At baseline, 3-months, 6-months, and 12-months
+1 more outcome measured

Conditions

Diabetes

Explore related trials

Diabetes MellitusHemoglobin A1C Measurement

Where it's being run

1 sites across 1 states
Michigan1

Who to contact

Minal R Patel
[email protected]
734-763-0087
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age: 18 years of age or older
Diabetes diagnosis: Documented diagnosis of diabetes (Type 1 or Type 2) with prescribed anti-hyperglycemic medication
Glycemic control: Most recent (within the past 6 months) recorded hemoglobin A1c (HbA1c) level of: ≥7.5% for individuals ≤70 years of age and ≥8.0% for individuals between 70-75 years of age Prior study participation: Did not participate in the CareAvenue trial (R01DK116715)
Financial burden and/or social needs (meeting ONE or more of the following):
Financial decision-making: Self-identifies as primarily responsible for making own healthcare financial decisions (to address concerns about young adults dependent on family support).
Interest in assistance: Expresses interest in receiving assistance with unmet social needs.
Ability to participate: Able to complete the screening process in English (or Spanish/Arabic if materials available) on behalf of self.
Healthcare access: Receives or is able to receive care at Michigan Medicine (required for potential social worker referral).
Age: 18 years of age or older
Diabetes diagnosis: Self-reported diagnosis of diabetes (Type 1 or Type 2)
Glycemic control: Within the past 12 months, have had at least one hemoglobin A1c (HbA1c) level of: ≥7.5% for individuals ≤70 years of age and ≥8.0% for individuals ≥71 years of age AND A1c levels \<7.5% for individuals ≤70 years of age and \<8.0% for individuals ≥71 years of age
Experience navigating social or financial resources: Self-reported success in navigating financial assistance or social services resources
Ability to participate: Able to provide peer support in English (option to additionally provide support in Spanish and/or Arabic); Able to complete training; Able to make calls every other week with assigned participants; Able to submit call logs; Able to complete a brief survey about experience throughout participation.
Confidence in diabetes self-management: Self-reported confidence in ability to manage diabetes

Exclusion

Serious psychiatric disorder: Active diagnosis of schizophrenia, active psychosis, or other serious mental illness that would impair ability to engage in intervention (as determined by medical record review)
Cognitive impairment: Documented moderate to severe cognitive impairment that would prevent meaningful participation in study activities (as determined by medical record review)
Active substance use: Current active illicit drug use that would interfere with study participation (as determined by medical record review)
Pregnancy: Currently pregnant or planning pregnancy during the study period (due to expected A1c changes) (as determined by medical record review)
Glucose-altering medications: Currently taking medications that alter glucose metabolism as a side effect rather than for diabetes management, including: Chronic oral corticosteroids (≥2 weeks continuous use); Antipsychotic medications known to affect glucose; Other medications affecting glucose when NOT prescribed for diabetes management Note: GLP-1 agonists, SGLT2 inhibitors, and other diabetes medications are NOT excluded, regardless of whether they are also used for weight management
Limited life expectancy: Self-reported or documented comorbidity expected to limit life span to less than 3 years
Concurrent diabetes study participation: Currently enrolled in another diabetes intervention study
Institutionalized: Currently residing in a nursing home, assisted living facility, correctional facility, or another group setting that prevents them from participating on their own behalf
Cognitive impairment: Self-reported cognitive impairment that would prevent meaningful participation in study activities
Participation Concerns or Barriers: Self-reported concerns that would prevent meaningful participation in study activities
Limited life expectancy: Self-reported or documented comorbidity expected to limit life span to less than 3 years
Institutionalized: Currently residing in a nursing home, assisted living facility, correctional facility, or another group setting that prevents them from participating on their own

What this trial measures

  • HbA1cLabs will be drawn at 4 assessment points: At baseline, 3-months, 6-months, and 12-months

    This clinical marker of diabetes control will be measured via laboratory tests (blood draw)

  • Blood PressureReadings will be taken at 4 assessment points: At baseline, 3-months, 6-months, and 12-months

    All participants will receive an at-home Omron blood pressure monitor and will take two readings during each assessment